Back to homepage

Tag "Drugs Controller General of India"

Corbevax gets DCGI nod as heterologous booster for adults

Corbevax gets DCGI nod as heterologous booster for adults

🕔18:04, 4.Jun 2022

Hyderabad-based Pharmaceuticals firm Biological E Ltd (BE) on Saturday announced that its Covid-19 vaccine Corbevax has been cleared by the Drugs Controller General of India (DCGI) as a heterologous Covid-19 booster for 18 plus population after their primary vaccination with

Read Full Article
Corbevax gets EUA for children aged 5-12 years

Corbevax gets EUA for children aged 5-12 years

🕔06:54, 27.Apr 2022

Vaccine maker Biological E. Ltd on Tuesday announced that its Covid-19 vaccine Corbevax has received a nod from the Drugs Controller General of India (DCGI) for emergency use authorisation for the 5-12-year age group. Hyderabad, April 27 (IANS) Vaccine maker Biological

Read Full Article
DCGI grants EUA to 3 Covid vaccines for different age group of children

DCGI grants EUA to 3 Covid vaccines for different age group of children

🕔16:48, 26.Apr 2022

The Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for children of different age groups. New Delhi, April 26 (IANS) The Drugs Controller General of India (DCGI) on Tuesday approved

Read Full Article
Dr Reddy’s to soon launch Molnupirvair capsules

Dr Reddy’s to soon launch Molnupirvair capsules

🕔18:43, 28.Dec 2021

Hyderabad, Dec 28 (IANS) Dr Reddy’s Laboratories, which Tuesday received emergency-use authorisation from the Drugs Controller General of India (DCGI) to manufacture and market the oral anti-viral drug Molnupiravir for treatment of Covid-19, will soon launch its Molnupiravir capsules 200mg under

Read Full Article
Covaxin gets emergency use approval for kids aged 2-18 years

Covaxin gets emergency use approval for kids aged 2-18 years

🕔15:16, 12.Oct 2021

New Delhi, Oct 12 (IANS) The Hyderabad-based pharma major Bharat Biotech’s Covaxin has got the emergency use approval for children in the age group of 2 to 18 years from the Drugs Controller General of India (DCGA). The Subject Expert Committee

Read Full Article
Sputnik’s single-dose vax gets DCGI nod for Phase-III trials in India

Sputnik’s single-dose vax gets DCGI nod for Phase-III trials in India

🕔15:35, 15.Sep 2021

New Delhi, Sep 15  The Drugs Controller General of India (DCGI) has granted permission for the conducting of the Phase III bridging trials of Sputnik Light on the Indian population. The Sputnik Light is a single-dose Covid-19 vaccine of the

Read Full Article
Cipla gets nod to bring Moderna’s Covid vaccine to India

Cipla gets nod to bring Moderna’s Covid vaccine to India

🕔20:20, 29.Jun 2021

New Delhi, June 29  Mumbai-based pharma company Cipla will add Moderna to the list of Covid-19 vaccines available in India for restricted emergency use. Sources said that the company has received permission from Drugs Controller General of India (DCGI) to

Read Full Article
DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old

DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old

🕔12:30, 13.May 2021

New Delhi, May 13 The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of Covaxin (Covid vaccine) in the age group of two to 18-years-old to its manufacturer Bharat Biotech Ltd, Union Health

Read Full Article
DCGI approves DRDO’s anti-COVID drug for emergency use

DCGI approves DRDO’s anti-COVID drug for emergency use

🕔20:16, 8.May 2021

New Delhi, May 8  The Drugs Controller General of India has approved an anti-COVID-19 drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS) for emergency use, the Defence Ministry has said. An anti-Covid-19 therapeutic application of the

Read Full Article
All you need to know about the Sputnik V Covid jab

All you need to know about the Sputnik V Covid jab

🕔06:20, 14.Apr 2021

New Delhi, April 14  As Hyderabad-based pharmaceutical major Dr. Reddy’s Laboratories (DRL) announces it has received permission from the Drugs Controller General of India (DCGI) to import Sputnik V vaccine in India for restricted use in emergencies, here are a

Read Full Article
Centre disapproves administration of Covaxin to those below 18 yrs

Centre disapproves administration of Covaxin to those below 18 yrs

🕔05:37, 15.Jan 2021

New Delhi, Jan 15  In a major shift of narrative, the government has now disapproved the authorisation of Bharat Biotech’s Covid vaccine to people below 18 years of age whereas earlier, it was approved for children above the age of

Read Full Article